AP: DEA To Propose Rule Moving Cannabis To Schedule III

FH
Foley Hoag LLP
Contributor
Foley Hoag provides innovative, strategic legal services to public, private and government clients. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse experiences of our lawyers contribute to the exceptional senior-level service we deliver to clients.
Historic federal action would recognize medical benefits of cannabis and make Section 280E inapplicable to licensed cannabis operators.
United States Cannabis & Hemp
To print this article, all you need is to be registered or login on Mondaq.com.

Key Takeaways:

  • Historic federal action would recognize medical benefits of cannabis and make Section 280E inapplicable to licensed cannabis operators.
  • The AP reports that rescheduling would occur as a Proposed Rule subject to notice and comment rulemaking before it could become final – a lengthy process.
  • Announcement alone will have positive financial impact for cannabis operators.

AP is reporting that the Drug Enforcement Administration will propose a rule to reschedule cannabis to Schedule III under the Controlled Substance Act. The proposed rule is subject to review by the White House Office of Management and Budget before publication in the Federal Register, according to AP. The rescheduling rule will be subject to notice and comment rulemaking and potentially a hearing (an often lengthy process).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

AP: DEA To Propose Rule Moving Cannabis To Schedule III

United States Cannabis & Hemp
Contributor
Foley Hoag provides innovative, strategic legal services to public, private and government clients. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse experiences of our lawyers contribute to the exceptional senior-level service we deliver to clients.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More